Medical Research Council
- Country
- 🇬🇧United Kingdom
- Ownership
- -
- Established
- 1913-01-01
- Employees
- -
- Market Cap
- -
Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle
- Conditions
- First Posted Date
- 2008-01-09
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 660
- Registration Number
- NCT00589537
- Locations
- 🇬🇧
UCL Cancer Institute, London, England, United Kingdom
🇬🇧Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, England, United Kingdom
An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2015-09-23
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 486
- Registration Number
- NCT00532194
- Locations
- 🇬🇧
University College London, London, Greater London, United Kingdom
Studying Genes for Barrett's Esophagus in Brothers and Sisters
- Conditions
- First Posted Date
- 2007-08-15
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 400
- Registration Number
- NCT00516347
- Locations
- 🇬🇧
Hutchison Cancer Research Unit, Cambridge, England, United Kingdom
Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
- Conditions
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 1656
- Registration Number
- NCT00492258
- Locations
- 🇬🇧
Bristol Haematology and Oncology Centre, Bristol, England, United Kingdom
🇬🇧Dorset County Hospital, Dorchester, England, United Kingdom
🇬🇧Leicester Royal Infirmary, Leicester, England, United Kingdom
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Conditions
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2013-08-12
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 1520
- Registration Number
- NCT00483782
- Locations
- 🇦🇺
Cancer Therapy Centre at Liverpool Hospital, Liverpool, New South Wales, Australia
🇬🇧St. George's Hospital, London, England, United Kingdom
🇬🇧Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants, England, United Kingdom
Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery
- Conditions
- First Posted Date
- 2006-11-23
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 1000
- Registration Number
- NCT00403065
- Locations
- 🇬🇧
Wansbeck General Hospital, Ashington, England, United Kingdom
🇬🇧Sussex Cancer Centre at Royal Sussex County Hospital, Brighton, England, United Kingdom
🇬🇧Whiston Hospital, Prescot Merseyside, England, United Kingdom
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors
- Conditions
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 88
- Registration Number
- NCT00301782
- Locations
- 🇬🇧
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
🇬🇧Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham, England, United Kingdom
🇬🇧Leicester Royal Infirmary, Leicester, England, United Kingdom
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 11992
- Registration Number
- NCT00268476
- Locations
- 🇬🇧
West Suffolk Hospital, Bury St. Edmunds, England, United Kingdom
🇬🇧Derbyshire Royal Infirmary, Derby, England, United Kingdom
🇬🇧Russells Hall Hospital, Dudley, England, United Kingdom
Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 500
- Registration Number
- NCT00253591
- Locations
- 🇬🇧
Kings Mill Hospital, Nottinghamshire, England, United Kingdom
🇬🇧Worcester Royal Hospital, Worcester, England, United Kingdom
🇬🇧University Hospital of North Durham, Durham, England, United Kingdom
PRION-1: Quinacrine for Human Prion Disease
- Conditions
- First Posted Date
- 2005-03-04
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- Medical Research Council
- Target Recruit Count
- 160
- Registration Number
- NCT00104663
- Locations
- 🇬🇧
National Prion Clinic, London, United Kingdom